Debut Plus

₹32.5

▲ +1.25 +4.00%

As of 23 Oct 2026 · delayed

BSE Listed

Sudarshan Pharma Industries Ltd. (543828)

Volume: 40,000Avg Vol 1W: 66,400Avg Vol 1M: 1,40,36452W Range:₹18.5₹42.79
Key Ratios
Checked 5h ago
Market Cap₹780 Cr
Current Price₹32.5
Previous Close₹31.25
High / Low (52w)₹42.79 / ₹18.5
Volume40,000
Avg Vol (1W)66,400
Avg Vol (1M)1,40,364
Stock P/E30.94
Book Value₹6.67
Dividend Yield0%
ROE15.03%
ROA389.87%
Revenue (TTM)—
Revenue Growth—
Profit Margin343.2%
Total Debt—
Shares Outstanding25 Cr
Face Value—
EPS (TTM)₹1.01
P/B4.68
Debt / Equity1.6
50 DMA₹38
200 DMA₹32.32
Day change+4.00%
Price Chart
₹32.5▲ 40.63% · 1Y
₹42₹1938.0L
2025-10-27
2026-10-23

20-day avg volume: 1.4L shares

Pros
  • Healthy return on equity of 15.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 77% YoY.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹129 Cr₹116 Cr₹162 Cr₹145 Cr₹169 Cr₹168 Cr₹221 Cr₹174 Cr
EBITDA₹13 Cr₹8 Cr₹16 Cr₹11 Cr₹10 Cr₹11 Cr₹23 Cr₹16 Cr
Net Profit₹6 Cr₹3 Cr₹7 Cr₹4 Cr₹4 Cr₹4 Cr₹11 Cr₹6 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹508 Cr₹162 Cr₹142 Cr₹167 Cr₹158 Cr₹712 Cr₹200 Cr₹166 Cr
EBITDA₹40 Cr₹15 Cr₹11 Cr₹11 Cr₹12 Cr₹56 Cr₹21 Cr₹16 Cr
Net Profit₹16 Cr₹7 Cr₹4 Cr₹4 Cr₹4 Cr₹23 Cr₹10 Cr₹6 Cr
EPS0.66————0.97——
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹58 Cr₹99 Cr₹138 Cr₹232 Cr₹283 Cr₹402 Cr₹642 Cr
Total Liabilities₹38 Cr₹77 Cr₹108 Cr₹132 Cr₹171 Cr₹271 Cr₹485 Cr
Equity₹20 Cr₹23 Cr₹30 Cr₹101 Cr₹112 Cr₹131 Cr₹156 Cr
Total Debt———————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹1 Cr₹4 Cr₹-2 Cr₹-27 Cr₹8 Cr₹-29 Cr₹4 Cr
Investing₹-2 Cr₹-1 Cr₹-1 Cr₹-26 Cr₹-5 Cr₹-21 Cr₹-78 Cr
Financing₹0 Cr₹-1 Cr₹4 Cr₹66 Cr₹-12 Cr₹53 Cr₹79 Cr
Free Cash Flow₹1 Cr₹4 Cr₹-2 Cr₹-27 Cr₹8 Cr₹-29 Cr₹4 Cr
Shareholding
Promoter 57.81% Institutions 21.95% Public 20.24%
Efficiency & Working Capital
ROCE12.8%
Interest Coverage2.2
Dividend Payout—
Debtor Days121 d
Inventory Days114 d
Payable Days97 d
Cash Conversion Cycle137 d
Working Capital Days235 d
Shareholding Details

As of 2026-09-30

Promoter57.8%
FII21.9%
DII0%
Institutions21.9%
Public20.2%
Promoter Pledge23.3%
No. of Shareholders1,250
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2023Sept 2023Mar 2024Sept 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Aug 2026Sept 2026
Promoters57.4%57.4%57.4%57.4%57.4%57.4%57.4%57.4%57.4%58.9%58.9%57.8%
FIIs3.6%1.4%1.4%13.1%18.5%19.5%20.8%19.8%19.9%19.4%19.9%21.9%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public39%41.2%41.2%29.5%24.2%23.1%21.8%22.8%22.7%21.7%21.2%20.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%1.4%0%23.3%
No. of Shareholders1,2449839137871,2121,3271,3831,4071,3461,2311,2171,250
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Sachin Vasantrai MehtaShareholding of Promoter and Promoter Group27.8%7.07 Cr
Hemal Vasantrai MehtaShareholding of Promoter and Promoter Group26.9%6.85 Cr
Century India Opportunity Fund PcPublic Shareholding3.2%81,00,000
Saumik Ketankumar DoshiPublic Shareholding2.8%72,00,000
Eminence Global Fund Pcc- Eubilia Capital PartnersPublic Shareholding2.8%70,52,000
Ebisu Global Opportunities Fund LimitedPublic Shareholding1.9%49,00,000
Unbounded Opportunities Fund Spc -alpha Investments SpPublic Shareholding1.9%48,11,730
North Star Opportunities Fund Vcc-bull Value IncorPublic Shareholding1.7%42,08,000
Coeus Global Opportunities FundPublic Shareholding1.7%41,96,000
Minerva Ventures FundPublic Shareholding1.6%39,88,000
Bridge India FundPublic Shareholding1.6%39,80,000
Nexpact LimitedPublic Shareholding1.5%38,48,000
Pine Oak Global FundPublic Shareholding1.3%32,16,000
Devangi Hemal MehtaShareholding of Promoter and Promoter Group0.9%22,94,070
Namrata Sachin MehtaShareholding of Promoter and Promoter Group0.7%16,45,120
Hemal V Mehta Huf .Shareholding of Promoter and Promoter Group0.7%16,45,120
Sachin V Mehta Huf .Shareholding of Promoter and Promoter Group0.7%16,45,120
Vasantray Ratilal MehtaShareholding of Promoter and Promoter Group0.2%4,93,190
Jatin Vasantrai MehtaShareholding of Promoter and Promoter Group0.1%1,64,470
Preeti Rajesh MuniShareholding of Promoter and Promoter Group0%0
Shreeya Hemal MehtaShareholding of Promoter and Promoter Group0%0
Nehaben Maheshkumar GandhiShareholding of Promoter and Promoter Group0%0
Krunal Maheshbhai GandhiShareholding of Promoter and Promoter Group0%0
Rajvi Amit SanghviShareholding of Promoter and Promoter Group0%0
Ravindra Anantrai MehtaShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Hemal V Mehta Huf .16,45,000100%2026-09-30
Sachin V Mehta Huf .14,78,14789.9%2026-09-30
Vasantray Ratilal Mehta4,93,190100%2026-09-30
Hemal Vasantrai Mehta1.32 Cr19.3%2026-09-30
Jatin Vasantrai Mehta1,64,470100%2026-09-30
Sachin Vasantrai Mehta1.32 Cr18.7%2026-09-30
Devangi Hemal Mehta22,94,000100%2026-09-30
Namrata Sachin Mehta16,45,000100%2026-09-30
Board of Directors
NameDesignationYear
Hemal V MehtaCMD & Director.2025
Sachin V MehtaED / Joint MD / CFO / Promoter2025
Umesh LuthraIndependent Non Exe. Director2025
JAYA ANKUR SINGHANIAIndependent Non Exe. Director2025
Rushabh Prashant PatilIndependent Non Exe. Director2025
ANIL BALKRISHNA GHOGARENon-Exec & Non-Independent Dir2025
NIRAV KISHOR KUMAR SHAHCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Chemical Division₹96 Cr68.7%
Pharmaceutical Division₹43 Cr31.3%
Segments — Geography
RegionRevenueShare
India₹646 Cr96.7%
Rest of the world₹22 Cr3.3%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1352424
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-12Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025120052138
20254004412
20253002914
Company Information
Incorporated2008
ChairmanHemal V Mehta
AuditorNGST & Associates
Investor Email[email protected]
🌐 www.sudarshanpharma.com ↗

📍 301 3rd Floor Aura Biplex, SV Road Borivali(West), Mumbai, Maharashtra, 400092

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search